1,392 reports of this reaction
3.9% of all NOREPINEPHRINE BITARTRATE reports
#2 most reported adverse reaction
HYPOTENSION is the #2 most commonly reported adverse reaction for NOREPINEPHRINE BITARTRATE, manufactured by Deseret Biologicals, Inc.. There are 1,392 FDA adverse event reports linking NOREPINEPHRINE BITARTRATE to HYPOTENSION. This represents approximately 3.9% of all 35,563 adverse event reports for this drug.
Patients taking NOREPINEPHRINE BITARTRATE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among NOREPINEPHRINE BITARTRATE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for NOREPINEPHRINE BITARTRATE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 1,392 FDA reports for NOREPINEPHRINE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.9% of all adverse event reports for NOREPINEPHRINE BITARTRATE, making it one of the most commonly reported side effect.
If you experience hypotension while taking NOREPINEPHRINE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.